Literature DB >> 17474557

Tuberculosis in chronic kidney disease.

R K C Venkata1, S Kumar, R P Krishna, S B Kumar, S Padmanabhan, S Kumar.   

Abstract

BACKGROUND: The incidence of tuberculosis is high in chronic kidney disease (CKD) which needs a high index of suspicion, early diagnosis and management for gratifying outcome. MATERIALS: The clinical, laboratory profile, management and outcome of tuberculosis in 36 patients with chronic kidney disease between 2000 and 2005 constitute the material of this study.
RESULTS: During this study period, over 900 chronic renal failure patients were evaluated in our unit and 36 of them were found to have tuberculosis, the incidence being 4%. In majority (69.4%), tuberculosis was observed in association with CKD Stage V. Age range was 25 - 77 years, male : female ratio was 33 : 3. Fever, malaise and weight loss were the commonest symptoms observed at presentation. Extrapulmonary tuberculosis (23 patients, 63.8%) predominated over pulmonary tuberculosis (10 patients, 36.1%). Tuberculin skin test was negative in 23 patients (63.8%). The diagnosis of tuberculosis was confirmed by tissue or specimen examination in 17 patients (47.2%) and in the rest it was empirical basing on clinical picture, pleural fluid analysis and radiological tests. All the patients were planned for a minimum period of 9-month antituberculous therapy (ATT). Of them, 17 patients (47.2%) were cured from tuberculosis and did not relapse, 9 patients (25%) died during treatment and 10 patients were lost for follow-up. Two patients were managed for anti-tuberculous therapy-related side effects: hepatotoxicity and psychosis.
CONCLUSIONS: We observed a 4% incidence of tuberculosis in CKD. Extrapulmonary form of tuberculosis predominated over pulmonary form. Fever and malaise were important clues for suspicion of tuberculosis. Tuberculin skin test was negative in the majority. Diagnostic confirmation was possible in 47.2% of patients and in the rest it was based on clinical suspicion, pleural fluid analysis and radiological findings. Cure from tuberculosis was observed in 47.2% of patients with antituberculous therapy.

Entities:  

Mesh:

Year:  2007        PMID: 17474557     DOI: 10.5414/cnp67217

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  18 in total

1.  Completion and Adverse Drug Events of Latent Tuberculosis Infection Treatment in Patients Receiving Dialysis: Predictors and Impacts of Different Regimens in a Prospective Cohort Study.

Authors:  Shu-Yung Lin; Jia-Yih Feng; Chih-Yuan Lee; Yi-Chih Lin; Yu-Hsiang Chou; Kuan-Yin Lin; Yu-Feng Wei; Shu-Wen Lin; Chin-Hao Chang; Ping-Huai Wang; Chin-Chung Shu; Jann-Yuan Wang; Chong-Jen Yu
Journal:  Antimicrob Agents Chemother       Date:  2021-02-17       Impact factor: 5.191

2.  A case of disseminated tuberculosis after the initiation of hemodialysis.

Authors:  Jumpei Hasegawa; Sachiko Wakai
Journal:  CEN Case Rep       Date:  2013-04-10

3.  Extrapulmonary tuberculosis presented as fever of unknown origin in two patients with endstage kidney disease not on dialysis: usefulness of 18-FDG-PET/CT in the diagnostic localization of fever of unknown origin.

Authors:  Shunsuke Yamada; Kenji Ueki; Yasuhiro Kawai; Teppei Sako; Yukiko Shimomura; Akihiro Tsuchimoto; Shigeru Tanaka; Rei Matsui; Hiroto Maeda; Masanori Tokumoto; Hiroaki Ooboshi; Takanari Kitazono; Kazuhiko Tsuruya
Journal:  CEN Case Rep       Date:  2015-04-21

4.  Incidence, etiopathogenesis and pathological aspects of genitourinary tuberculosis in India: A journey revisited.

Authors:  Prasenjit Das; Arvind Ahuja; Siddhartha Datta Gupta
Journal:  Indian J Urol       Date:  2008-07

5.  Extrapulmonary tuberculosis in a hemodialysis patient with unusual clinical presentation.

Authors:  Tansu Sav; Bulent Tokgoz; Murat H Sipahioglu; Ertugrul Mavili; Oktay Oymak; Cengiz Utas
Journal:  Int Urol Nephrol       Date:  2009-04-29       Impact factor: 2.370

6.  Impact of Fluoroquinolone Exposure Prior to Tuberculosis Diagnosis on Clinical Outcomes in Immunocompromised Patients.

Authors:  Ju Young Lee; Hyun Jung Lee; Yong Kyun Kim; Shinae Yu; Jiwon Jung; Yong Pil Chong; Sang-Oh Lee; Sang-Ho Choi; Tae Sun Shim; Yang Soo Kim; Jun Hee Woo; Sung-Han Kim
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

7.  High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test.

Authors:  S S J Lee; K J Chou; I J Su; Y S Chen; H C Fang; T S Huang; H C Tsai; S R Wann; H H Lin; Y C Liu
Journal:  Infection       Date:  2008-12-10       Impact factor: 3.553

8.  Predictors and prevalence of latent tuberculosis infection in patients receiving long-term hemodialysis and peritoneal dialysis.

Authors:  Chin-Chung Shu; Vin-Cent Wu; Feng-Jung Yang; Sung-Ching Pan; Tai-Shuan Lai; Jann-Yuan Wang; Jann-Tay Wang; Li-Na Lee
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

9.  Sternal tuberculosis in a patient with chronic kidney disease.

Authors:  M Yadla; S Reddy; P Sriramnaveen; C K Kishore; A V S S N Sridhar; A Y Lakshmi; B Vijayalakshmi; B Phanindra; V Sivakumar
Journal:  Indian J Nephrol       Date:  2013-01

10.  Comparison of the Prevalence of Latent Tuberculosis Infection among Non-Dialysis Patients with Severe Chronic Kidney Disease, Patients Receiving Dialysis, and the Dialysis-Unit Staff: A Cross-Sectional Study.

Authors:  Chin-Chung Shu; Chia-Lin Hsu; Chih-Yuan Lee; Jann-Yuan Wang; Vin-Cent Wu; Feng-Jung Yang; Jann-Tay Wang; Chong-Jen Yu; Li-Na Lee
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.